Publication:
Counterfeit and substandard drugs in Sub-Saharan Africa may pose a major hurdle to H3Africa’s initiative ‎to study genetics of kidney disease progression

dc.contributor.authorBanerjee, Yajnavalka
dc.date.accessioned2022-07-20T07:49:03Z
dc.date.available2022-07-20T07:49:03Z
dc.date.issued2017
dc.description.abstractTo the Editor:‎ The Human Heredity and Health in Africa Kidney Disease Research Network aims to investigate the ‎genetics of renal disease progression.1 Diabetes mellitus and hypertension have emerged as the ‎commonest cause of endstage renal disease in Sub-Saharan Africa.2 Additionally, obstructive uropathy ‎‎(observed in malaria), HIV infection, and toxic nephropathies also contribute considerably. Therefore, ‎apposite management of the above conditions is essential before mapping the phenotype of renal-‎disease progression to the genotype. (Continued...)‎en_US
dc.identifier.other‎204-2017.55‎
dc.identifier.urihttps://repository.mbru.ac.ae/handle/1/984
dc.language.isoenen_US
dc.subjectLetters to the editoren_US
dc.titleCounterfeit and substandard drugs in Sub-Saharan Africa may pose a major hurdle to H3Africa’s initiative ‎to study genetics of kidney disease progressionen_US
dc.typeArticleen_US
dspace.entity.typePublicationen_US

Files